We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$586M
AUM Growth
-$19.4M
Cap. Flow
-$11.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
17.48%
Holding
250
New
15
Increased
23
Reduced
114
Closed
18

Top Sells

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$4.27M
2
ABBV icon
AbbVie
ABBV
+$3.73M
3
BX icon
Blackstone
BX
+$3.24M
4
GTLB icon
GitLab
GTLB
+$2.72M
5
MDB icon
MongoDB
MDB
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 36.08%
2 Industrials 13.65%
3 Energy 8.19%
4 Healthcare 7.99%
5 Consumer Discretionary 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
176
ASML
ASML
$675B
-295
Closed -$214K
BNY
177
Bank of New York Mellon
BNY
$108B
-4,937
Closed -$220K
CCI icon
178
Crown Castle
CCI
$32.7B
-18,684
Closed -$2.13M
FTNT icon
179
Fortinet
FTNT
$112B
-3,105
Closed -$235K
HBAN icon
180
Huntington Bancshares
HBAN
$35.1B
-184,610
Closed -$1.99M
ITW icon
181
Illinois Tool Works
ITW
$81.4B
-823
Closed -$206K
NFLX icon
182
Netflix
NFLX
$292B
-4,810
Closed -$212K
RBLX icon
183
Roblox
RBLX
$34B
-7,022
Closed -$283K
SBUX icon
184
Starbucks
SBUX
$118B
-2,135
Closed -$211K
STT icon
185
State Street
STT
$50.9B
-33,491
Closed -$2.45M
TFC icon
186
Truist Financial
TFC
$63.2B
-61,610
Closed -$1.87M
WAB icon
187
Wabtec
WAB
$51.1B
-38,960
Closed -$4.27M
ZBH icon
188
Zimmer Biomet
ZBH
$17.7B
-1,495
Closed -$218K
MMP
189
DELISTED
Magellan Midstream Partners, L.P.
MMP
-4,219
Closed -$263K

Similar funds

Stanley-Laman Group's Q3 2023 Portfolio in Review

As of Q3 2023, Stanley-Laman Group held 250 positions worth $586M, down 3.2% from $605M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q3 2023 filing shows 15 new, 23 increased, 114 reduced and 18 closed positions. Its largest new stake was AstraZeneca: 26,476 shares worth $3.59M. The largest sale was Wabtec, an estimated $4.27M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Industrials and Energy.

  • Stanley-Laman Group's largest Q3 2023 buy was AstraZeneca: 26,476 shares worth $3.59M.
  • Stanley-Laman Group added most to HashiCorp, Inc. Class A Common Stock in Q3 2023, an estimated $4.5M increase.
  • Stanley-Laman Group's biggest Q3 2023 reduction was AbbVie, cutting an estimated $3.73M.
  • Stanley-Laman Group fully exited Wabtec in Q3 2023, selling an estimated $4.27M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $586M portfolio in Q3 2023.
  • Stanley-Laman Group opened 15 new positions and closed 18 in Q3 2023.
  • Stanley-Laman Group's portfolio value fell 3.2% quarter-over-quarter to $586M.

Based on Stanley-Laman Group's 13F filing for Q3 2023, filed 16 Oct 2023.